Total Payments
$3,147
2024 Payments
$347.29
Companies
19
Transactions
188
Medicare Patients
2,955
Medicare Billing
$310,791
Payment Breakdown by Category
Food & Beverage$3,147 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,147 | 188 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $961.15 | 70 | $0 (2023) |
| ABBVIE INC. | $670.61 | 39 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $311.97 | 17 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $311.37 | 15 | $0 (2024) |
| Merck Sharp & Dohme LLC | $184.97 | 10 | $0 (2024) |
| Braintree Laboratories, Inc. | $137.58 | 6 | $0 (2024) |
| Janssen Biotech, Inc. | $101.06 | 5 | $0 (2022) |
| Valeant Pharmaceuticals North America LLC | $91.07 | 3 | $0 (2017) |
| Ardelyx, Inc. | $80.86 | 5 | $0 (2024) |
| QOL Medical, LLC | $56.23 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $347.29 | 15 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($117.94) |
| 2023 | $196.40 | 10 | Takeda Pharmaceuticals U.S.A., Inc. ($61.89) |
| 2022 | $583.64 | 30 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($131.05) |
| 2021 | $211.41 | 14 | Gilead Sciences, Inc. ($182.17) |
| 2020 | $159.94 | 8 | Gilead Sciences, Inc. ($87.14) |
| 2019 | $262.10 | 21 | Gilead Sciences, Inc. ($129.56) |
| 2018 | $811.68 | 54 | AbbVie, Inc. ($353.94) |
| 2017 | $574.92 | 36 | AbbVie, Inc. ($235.28) |
All Payment Transactions
188 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Gastroenterology | ||||||
| 12/13/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: LIVER DISEASE | ||||||
| 12/11/2024 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: GI COLON PREP | ||||||
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/04/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: LIVER DISEASE | ||||||
| 10/15/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Gastroenterology | ||||||
| 06/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $42.50 | General |
| Category: Gastroenterology | ||||||
| 05/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI, HUMIRA | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: IMMUNOLOGY | ||||||
| 03/21/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/05/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: General - Therapies_ENDO | ||||||
| 02/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: Gastroenterology | ||||||
| 02/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $8.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/08/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $7.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Gastroenterology | ||||||
| 09/28/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/29/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.99 | General |
| 06/27/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/24/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/05/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.99 | General |
| 02/22/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/24/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 506 | 591 | $466,375 | $58,940 |
| 2022 | 14 | 695 | 828 | $597,117 | $76,491 |
| 2021 | 16 | 851 | 1,048 | $705,216 | $88,575 |
| 2020 | 17 | 903 | 1,068 | $677,942 | $86,785 |
Total Patients
2,955
Total Services
3,535
Medicare Billing
$310,791
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 91 | 143 | $74,920 | $14,756 | 19.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 79 | $27,129 | $4,747 | 17.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 33 | 33 | $59,334 | $4,691 | 7.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $26,775 | $4,685 | 17.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 49 | 49 | $64,974 | $4,526 | 7.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 28 | $18,861 | $3,990 | 21.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 19 | 19 | $28,918 | $3,501 | 12.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 24 | 24 | $36,528 | $3,482 | 9.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 20 | 20 | $27,540 | $3,315 | 12.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 29 | $9,860 | $2,872 | 29.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 13 | 13 | $27,235 | $2,799 | 10.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 40 | 40 | $20,120 | $2,226 | 11.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 24 | 24 | $28,056 | $2,124 | 7.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 16 | $3,840 | $1,054 | 27.4% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 37 | 39 | $12,285 | $174.85 | 1.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 143 | 225 | $58,950 | $14,582 | 24.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 69 | 74 | $49,847 | $12,068 | 24.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 71 | 71 | $94,146 | $6,617 | 7.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 53 | 74 | $25,160 | $6,238 | 24.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 46 | 46 | $82,708 | $6,093 | 7.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 28 | 28 | $38,556 | $5,358 | 13.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 25 | 25 | $52,375 | $5,267 | 10.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 32 | 32 | $48,704 | $4,735 | 9.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 22 | 22 | $33,484 | $4,119 | 12.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 44 | 46 | $53,774 | $3,963 | 7.4% |
About Dr. Thomas Imperato, M.D
Dr. Thomas Imperato, M.D is a Gastroenterology healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902871684.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Imperato, M.D has received a total of $3,147 in payments from pharmaceutical and medical device companies, with $347.29 received in 2024. These payments were reported across 188 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,147).
As a Medicare-enrolled provider, Imperato has provided services to 2,955 Medicare beneficiaries, totaling 3,535 services with total Medicare billing of $310,791. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Sacramento, CA
- Active Since 02/17/2006
- Last Updated 10/31/2017
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1902871684
Products in Payments
- Humira (Biological) $583.57
- XIFAXAN (Drug) $283.76
- ENTYVIO (Biological) $225.02
- SUTAB (Drug) $116.84
- STELARA (Biological) $101.06
- IBSRELA (Drug) $80.86
- DIFICID (Drug) $80.13
- ZEPATIER (Drug) $69.32
- RINVOQ (Biological) $47.87
- TRULANCE (Drug) $41.81
- RESMETIROM (Drug) $37.55
- Amitiza (Drug) $36.80
- GATTEX (Drug) $35.13
- Sucraid (Drug) $34.62
- XIFIXAN (Drug) $33.33
- Entyvio (Biological) $32.30
- XIFAXANIBSD (Drug) $30.95
- Talicia (Drug) $27.42
- Epclusa (Drug) $26.76
- OCALIVA (Drug) $25.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Sacramento
Dr. Joseph Leung, M.d, M.D
Gastroenterology — Payments: $382,939
Gastroenterology $382,939
Christopher Bowlus, M.d, M.D
Gastroenterology — Payments: $174,596
Gastroenterology $174,596
Dr. Antonio Mendoza Ladd, M.d, M.D
Gastroenterology — Payments: $84,349
Gastroenterology $84,349
Dr. Kuldeep Tagore, M.d, M.D
Gastroenterology — Payments: $53,535
Gastroenterology $53,535
Abdul Khaleq, Md, MD
Gastroenterology — Payments: $48,069
Gastroenterology $48,069
Dr. Valentina Medici, M.d, M.D
Gastroenterology — Payments: $30,237
Gastroenterology $30,237